[ ]   [ ]   [ ]                        [ ]      [ ]   [ ]

Ukraine - R_P - Mar 28, 2024 - 2:41pm
 
Breaking News - ScottFromWyoming - Mar 28, 2024 - 2:22pm
 
Orbiting Earth - oldviolin - Mar 28, 2024 - 2:19pm
 
YouTube: Music-Videos - oldviolin - Mar 28, 2024 - 2:17pm
 
• • • The Once-a-Day • • •  - oldviolin - Mar 28, 2024 - 2:13pm
 
Oldest Rock song on RP - Proclivities - Mar 28, 2024 - 2:11pm
 
Lyrics that strike a chord today... - oldviolin - Mar 28, 2024 - 2:06pm
 
Israel - R_P - Mar 28, 2024 - 2:03pm
 
Photos you have taken of your walks or hikes. - NoEnzLefttoSplit - Mar 28, 2024 - 12:21pm
 
Irony 101 - MrDill - Mar 28, 2024 - 12:21pm
 
Photography Forum - Your Own Photos - MrDill - Mar 28, 2024 - 12:15pm
 
RP automation with iOS Shortcuts App - pradler4kant - Mar 28, 2024 - 11:57am
 
Baseball, anyone? - ScottFromWyoming - Mar 28, 2024 - 11:46am
 
The Obituary Page - ScottFromWyoming - Mar 28, 2024 - 11:31am
 
Talk Behind Their Backs Forum - VV - Mar 28, 2024 - 11:27am
 
March 2024 Photo Theme - Many - NoEnzLefttoSplit - Mar 28, 2024 - 11:07am
 
Wordle - daily game - rgio - Mar 28, 2024 - 11:00am
 
Bug Reports & Feature Requests - Beaker - Mar 28, 2024 - 9:30am
 
NY Times Strands - geoff_morphini - Mar 28, 2024 - 8:37am
 
NYTimes Connections - geoff_morphini - Mar 28, 2024 - 8:29am
 
Radio Paradise Comments - pilgrim - Mar 28, 2024 - 8:19am
 
Business as Usual - black321 - Mar 28, 2024 - 8:09am
 
Trump - rgio - Mar 28, 2024 - 7:29am
 
Outstanding Covers - thisbody - Mar 28, 2024 - 5:51am
 
Today in History - DaveInSaoMiguel - Mar 28, 2024 - 4:28am
 
USA! USA! USA! - R_P - Mar 27, 2024 - 7:40pm
 
Little known information...maybe even facts - haresfur - Mar 27, 2024 - 6:21pm
 
Live Music - oldviolin - Mar 27, 2024 - 5:08pm
 
RightWingNutZ - R_P - Mar 27, 2024 - 3:48pm
 
Please Don't Post Here - Red_Dragon - Mar 27, 2024 - 11:02am
 
Motivational Office Cliches... - NoEnzLefttoSplit - Mar 26, 2024 - 10:20pm
 
(Big) Media Watch - Red_Dragon - Mar 26, 2024 - 6:18pm
 
Solar / Wind / Geothermal / Efficiency Energy - islander - Mar 26, 2024 - 8:00am
 
Is there any DOG news out there? - Beez - Mar 26, 2024 - 7:24am
 
Food - Steely_D - Mar 26, 2024 - 1:41am
 
Vinyl Only Spin List - kurtster - Mar 25, 2024 - 6:56pm
 
Derplahoma! - Red_Dragon - Mar 25, 2024 - 3:48pm
 
Frequent drop outs (The Netherlands) - kingen - Mar 25, 2024 - 2:43pm
 
China - R_P - Mar 25, 2024 - 11:59am
 
Musky Mythology - R_P - Mar 25, 2024 - 11:20am
 
Play history seems to indicate that I"m streaming 24/7, b... - jarro - Mar 25, 2024 - 10:44am
 
April 8th Partial Solar Eclipse - Coaxial - Mar 24, 2024 - 6:22pm
 
New Music - KurtfromLaQuinta - Mar 24, 2024 - 5:07pm
 
Dental Floss Tycoons, and other Montana Myths, Facts, and... - Red_Dragon - Mar 24, 2024 - 12:32pm
 
Basketball - oldviolin - Mar 23, 2024 - 2:50pm
 
What Makes You Laugh? - ScottFromWyoming - Mar 23, 2024 - 1:54pm
 
Joe Biden - kurtster - Mar 23, 2024 - 11:17am
 
Technical Streaming Note for Nerdy RP DIYers - sjagminas1 - Mar 23, 2024 - 10:16am
 
Museum Of Bad Album Covers - Proclivities - Mar 23, 2024 - 8:56am
 
Other Medical Stuff - Antigone - Mar 22, 2024 - 3:06pm
 
Country Up The Bumpkin - oldviolin - Mar 22, 2024 - 11:06am
 
Pernicious Pious Proclivities Particularized Prodigiously - Red_Dragon - Mar 22, 2024 - 9:17am
 
Memorials - Remembering Our Loved Ones - Bill_J - Mar 21, 2024 - 8:54pm
 
Can you afford to retire? - DaveInSaoMiguel - Mar 21, 2024 - 2:15pm
 
Mixtape Culture Club - KurtfromLaQuinta - Mar 21, 2024 - 11:10am
 
What Did You See Today? - KurtfromLaQuinta - Mar 20, 2024 - 5:13pm
 
Annoying stuff. not things that piss you off, just annoyi... - ScottFromWyoming - Mar 20, 2024 - 4:31pm
 
Upcoming concerts or shows you can't wait to see - Antigone - Mar 20, 2024 - 3:10pm
 
Russia - NoEnzLefttoSplit - Mar 20, 2024 - 11:44am
 
2024 Elections! - Lazy8 - Mar 20, 2024 - 7:26am
 
Economix - R_P - Mar 19, 2024 - 4:36pm
 
Name My Band - DaveInSaoMiguel - Mar 19, 2024 - 10:53am
 
Delicacies: a..k.a.. the Gross Food forum - DaveInSaoMiguel - Mar 19, 2024 - 10:12am
 
New Forum Member on "What Makes RP Great" - miamizsun - Mar 19, 2024 - 4:38am
 
Cache stopped working on old Android Phone - Eisenwindel - Mar 19, 2024 - 1:50am
 
Cryptic Posts - Leave Them Guessing - Bill_J - Mar 18, 2024 - 8:23pm
 
Damn Dinosaurs! - oldviolin - Mar 18, 2024 - 8:16pm
 
One Partying State - Wyoming News - geoff_morphini - Mar 18, 2024 - 3:58pm
 
Great guitar faces - skyguy - Mar 18, 2024 - 3:33pm
 
Despots, dictators and war criminals - R_P - Mar 18, 2024 - 12:41pm
 
Uploading Music - dischuckin - Mar 18, 2024 - 11:55am
 
Media Matters - thisbody - Mar 18, 2024 - 10:03am
 
NASA & other news from space - miamizsun - Mar 18, 2024 - 4:13am
 
MEALTICKET - drinpt - Mar 17, 2024 - 4:13am
 
What makes you smile? - Steely_D - Mar 16, 2024 - 7:31pm
 
Index » Radio Paradise/General » General Discussion » XPRIZE & Singularity University Page: 1, 2, 3  Next
Post to this Topic
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2022 - 8:41am

didn't see an AI thread so this will have to do for now...




edit: full version


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: May 31, 2019 - 3:15pm


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Mar 12, 2019 - 6:12am

sort of the euro-version of singularity u 

Hello Tomorrow

We are a global non-profit on a mission to unlock the potential of deep technologies to solve the world's toughest challenges, by highlighting, empowering and connecting the most promising deeptech entrepreneurs across the globe with the right enablers.






black321

black321 Avatar

Location: An earth without maps
Gender: Male


Posted: Jan 25, 2019 - 9:59am



 miamizsun wrote:
busy day ahead, but i'd like to leave you with something good to snack on


 

I'll see your exponential tech, and raise you one big brother:

https://www.wired.com/story/is...
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 25, 2019 - 4:21am

busy day ahead, but i'd like to leave you with something good to snack on


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Sep 16, 2018 - 8:16am



an awesome display of people using technology to solve the biggest problems we have today (and in the future)  

this is much watch stuff (esp the energy presentation with ramez naam)

enjoy  










miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 21, 2018 - 3:48pm

Landmark FDA Approval Brings Powerful Gene Silencing Method to Market

Earlier this month, the FDA approved an entirely new family of drugs, one so powerful that it could put CRISPR-based gene therapy to shame. Backed by two decades of research and a Nobel Prize, these drugs have the ability to cure inherited diseases—and do so without actually needing to edit the delicate genome.

The green-lit therapy is patisiran, a drug ten years in the making by the Cambridge-based Alnylam for genetic nerve damage. But in this rare case, the nature of the drug is perhaps more significant: patisiran is based on a technology called RNA interference, or RNAi, which allows doctors to silence genes that aren’t properly functioning.

Patisiran is just the tip of the iceberg. In theory, RNAi has the potential to cure any disease caused by “bad” proteins, such as stroke, Alzheimer’s, high cholesterol, or other neurodegenerative disorders. The potential is so grand that scientists have long dubbed the technology a way to “drug the undruggable.”

“This approval is part of a broader wave of advances that allow us to treat disease by actually targeting the root cause, enabling us to arrest or reverse a condition, rather than only being able to slow its progression or treat its symptoms,” said FDA commissioner Scott Gottlieb in a press release. “New technologies like RNA inhibitors, that alter the genetic drivers of a disease, have the potential to transform medicine, so we can better confront and even cure debilitating illnesses.”

With other RNA-based therapies hurtling down the drug development pipeline, it’s likely we’ll be seeing more of these drugs soon. Here’s what you need to know.
more


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 21, 2018 - 1:46pm

i'm fairly certain that anyone can sign up and livestream this summit

line up of speakers/presenters here

e
njoy
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2018 - 6:33am

 islander wrote:

{#Ask}  

So when do we get to trial run the set?

 
when is now a good time?    {#Cheers}

miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 17, 2018 - 6:23am



Proclivities

Proclivities Avatar

Location: Paris of the Piedmont
Gender: Male


Posted: Aug 7, 2018 - 9:21am

 miamizsun wrote:

thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}
 
Good to see you; your secret is safe.
spy smasher
islander

islander Avatar

Location: Seattle
Gender: Male


Posted: Aug 7, 2018 - 9:03am

 miamizsun wrote:

thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}
 
{#Ask}  

So when do we get to trial run the set?


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 7, 2018 - 8:37am

 NoEnzLefttoSplit wrote:

Good to see you back J!

 

 
thanks! {#Wave}

i've been crazy busy with some "other" stuff

upgrading my solutions capability and whatnot

or at least that's how i'm trying to rationalize it

{#Biggrin}

NoEnzLefttoSplit

NoEnzLefttoSplit Avatar

Gender: Male


Posted: Aug 7, 2018 - 8:18am

 miamizsun wrote:
from last october (i think there's an updated version of this video)
 

 
Good to see you back J!

 
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Aug 6, 2018 - 2:47pm

from last october (i think there's an updated version of this video)


 


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: May 22, 2018 - 4:12am

we need people with vision swinging for the fence...


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Apr 9, 2018 - 1:46pm


see more here
miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 16, 2018 - 4:23am

Gene Therapy Had a Breakthrough 2017—2018 May Be Even Better

Gene therapy had a hell of a 2017. After decades of promises but failed deliveries, last year saw the field hitting a series of astonishing home runs.

The concept of gene therapy is elegant: like computer bugs, faulty letters in the human genome can be edited and replaced with healthy ones.

But despite early enthusiasm, the field has suffered one setback after another. At the turn of the century, the death of an 18-year-old patient with inherited liver disease after an experimental gene therapy treatment put the entire field into a deep freeze.

But no more. Last year marked the birth of gene therapy 2.0, in which the experimental dream finally became a clinical reality. Here’s how the tech grew into its explosive potential—and a sneak peek at what’s on the horizon for 2018.

1. Bad Blood, Meet CAR-T

It sounds like magic: you harvest a patient’s own immune cells, dose them with an injection of extra genetic material, and turn them into living cancer-hunting machines.

But in 2017, the FDA approved a double whammy of CAR-T immunotherapies. The first, green-lighted in August, helps kids and young adults battle an especially nasty form of leukemia called B-cell acute lymphoblastic leukemia. Two months later, a therapy for adults with non-Hodgkin lymphoma hit the scene.

Together, these approvals marked the long-anticipated debut of gene therapy in the US market. Previously, Europe has led the charge with its approval of Glybera in 2015, a gene therapy that reduces fatty acid buildup in the bloodstream.

The historic nod of confidence for CAR-T has already sparked widespread interest among academics and drug companies alike at finding new targets for the upgraded immune cells (the “T” in “CAR-T” stands for T-cell, a type of immune cell). CAR-T is especially exciting for the cancer field because it helps people who don’t respond to other classic treatments, such as chemotherapy.

Already in the works are treatments that target multiple myeloma, which causes multiple tumors in the bone or soft tissue, and glioblastoma, an aggressive brain tumor for which there is no cure.

But the technology’s potential is hardly limited to cancer. Last year, a preliminary study in two monkeys showed that genetically engineered stem cells can suppress and even eradicate HIV infections. The study, though small, tantalizingly suggests a whole new way to battle HIV after three decades of fruitless search for a vaccine. With multiple CAR-T therapies going through the pipeline, 2018 may very likely welcome new members onto the gene therapy scene.



more here...




miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 11, 2018 - 9:26am

a new cancer xprize...{#Cheers}

The Future of Cancer Treatment Is Personalized and Collaborative

Just a few years ago, microscopes were the primary tool used in cancer diagnoses, but we’ve come a long way since.

“We still look at a microscope, we still look at what organ the cancer started in,” Wender said. “But increasingly we’re looking at the molecular signature. It’s not just the genomics, and it’s not just the genes. It’s also the cellular environment around that cancer. We’re now targeting our therapies to the mutations that are found in that particular cancer.”

Cancer treatments in the past have been largely reactionary, but they don’t need to be. Most cancer is genetic, which means that treatment can be preventative. This is one reason why newer cancer treatment techniques are searching for actionable targets in the specific gene before the cancer develops.

When asked how artificial intelligence and machine learning technologies are reshaping clinical trials, Wender acknowledged that how clinical trials have been run in the past won’t work moving forward.

“Our traditional ways of learning about cancer were by finding a particular cancer type and conducting a long clinical trial that took a number of years enrolling patients from around the country. That is not how we’re going to learn to treat individual patients in the future.”

Instead, Wender emphasized the need for gathering as much data as possible, and from as many individual patients as possible. This data should encompass clinical, pathological, and molecular data and should be gathered from a patient all the way through their final outcome. “Literally every person becomes a clinical trial of one,” Wender said.

For the best cancer treatment and diagnostics, Wender says the answer is to make the process collaborative by pulling in resources from organizations and companies that are both established and emerging.

It’s no surprise to hear that the best solutions come from pairing together uncommon partners to innovate.


miamizsun

miamizsun Avatar

Location: (3283.1 Miles SE of RP)
Gender: Male


Posted: Jan 9, 2018 - 6:43am

it's part of moving forward...

New Research Suggests Immunity to CRISPR Gene Editing Poses a Challenge

The issue arises in how the Cas9 proteins researchers use are manufactured.

The authors of the study noted that the most widely-used versions of the protein are extracted from the bacteria Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). In bioengineering, particular bacteria—usually selected for being widely available and easy to cultivate—are often used to synthesize particular proteins. For example, most of our medical insulin is made from genetically modified E. coli. The researchers behind the study questioned whether because S. aureus and S. pyogenes regularly infect humans we might have built up some resistance to their proteins already. The infections they cause, often called strep and staph, are widespread enough that most people can be expected to have been exposed to the bacteria.

The study discovered that in many cases, human immune systems produced T-cells that specifically responded to the Cas9 protein from Staphylococcus aureus. This suggests that attempts at therapeutic use would cause an adaptive immune response that might render the therapy ineffective. Indeed, the authors of the paper wrote that use of these proteins in those who’ve been exposed to this bacteria could be harmful. “It may even result in significant toxicity to patients,” according to Stanford University’s Matthew Porteus, a  senior author of the paper. A paper by Wei Leong Chew suggests, “If left unchecked…it could lead to mortality.”

The authors of the paper wanted to ensure immune issues weren’t overlooked. “Like any new technology, you want to identify potential problems and engineer solutions for them,” according to Porteus. “And I think that’s where we’re at. This is an issue that should be addressed.”

But this is far from the end for CRISPR.


Page: 1, 2, 3  Next